Results 221 to 230 of about 41,710 (302)

Draft a protocol for an observational study for a fixed-dose combination product including metformin & linagliptin in patients with type 2 diabetes [PDF]

, 2016
Καραούλης, Ελευθέριος
core   +1 more source

A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez, Juan C. Garnica‐Cuellar, Miguel Ángel Colín‐García, Aldo Ferreira‐Hermosillo, Silvia A. Jiménez‐Ramos, Aleida Y. Contreras‐Sandoval, Patricia Cruz‐Puente, Manuel Duarte‐Vega   +7 more
wiley   +1 more source

A case of bullous pemphigoid and renal disease after dipeptidyl peptidase 4 inhibitor administration. [PDF]

CEN Case Rep
Suenaga A, Sawa N, Oba Y, Ikuma D, Sekine A, Yamanouchi M, Hasegawa E, Mizuno H, Suwabe T, Hayashi N, Kono K, Kinowaki K, Ohashi K, Miyazono M, Yamaguchi Y, Ubara Y.   +15 more
europepmc   +1 more source

Hypolipidemic and Hypoglycemic Activity of Goat Milk–Derived Peptides

Food Frontiers, Volume 7, Issue 3, May 2026.
Goat milk–derived bioactive peptides IASAEPTVH, LSTSEENSKK, and TEDELQDK exerted favorable hypolipidemic and hypoglycemic properties. ABSTRACT The prevalence of diabetes and hyperlipidemia worldwide has increased in recent decades. This study aimed to investigate the potential hypoglycemic and hypolipidemic effects of bioactive peptides derived from ...
Rui Wang, Yun Yang, Xinhua Ouyang, Rong He, Xingyun Wang, Xiaoqing Chen   +5 more
wiley   +1 more source

Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India. [PDF]

Cureus
Kalra S, Bhattacharya S, Dhingra A, Das S, Kapoor N, Shaikh S, Kolapkar V, Lokesh Kumar RV, Patel K, Kotwal R.   +9 more
europepmc   +1 more source

Integrative Insights Into Bioactive Peptides in Milk Fermented With Autochthonous and Commercial Cultures Using High‐Throughput Peptidomics and Machine Learning

Food Frontiers, Volume 7, Issue 3, May 2026.
This article highlights the crucial role of starter culture selection in shaping the peptide profile of fermented dairy drinks. Using high‐throughput peptidome profiling, the study demonstrates that different starter cultures yield distinct quantities and types of bioactive peptides, with excessive microbial combinations potentially reducing peptide ...
Martina Banić, Ana Butorac, Katarina Butorac, Blaženka Kos, Andreja Leboš Pavunc, Jagoda Šušković, Jasna Novak   +6 more
wiley   +1 more source

Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor. [PDF]

Adv Ther
Evans M, Husain M, Srivastava A, Mangla KK, Kuhlman AB, Lingvay I.   +5 more
europepmc   +1 more source

Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent [PDF]

, 2015

core   +1 more source

Targeting of Gut Microbiota by Bioactive Peptides for the Improvement of Metabolic Diseases: A Review

Food Frontiers, Volume 7, Issue 3, May 2026.
Bioactive peptides (BPs) derived from dietary proteins modulate the gut microbiotametabolism axis by reshaping microbial composition and regulating key metabolites, including short‐chain fatty acids. BPs also enhance intestinal barrier integrity and immune homeostasis, thereby reducing inflammation.
Jiao Li, Yongchao Chen, Zhihua Li, Gang Liu, Hongmei Jiang, Jun Fang, Sujuan Ding   +6 more
wiley   +1 more source

Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial". [PDF]

Diabetes Obes Metab
europepmc   +1 more source